Skip to content

Clinical trials

Pulmonary Eosinophilia trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pulmonary Eosinophilia Country / region: United Kingdom Clear all

24 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20101
20131
20142
20151
20161
20172
20182
20191
20202
20212
20222
20234
20241
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed14
Active, not recruiting4
Terminated3
Recruiting2
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca5
Areteia Therapeutics4
GlaxoSmithKline4
University Hospital Southampton NHS Foundation Trust3
AnaptysBio, Inc.1
Chiesi Farmaceutici S.p.A.1
GB001, Inc, a wholly owned subsidiary of Gossamer Bio, Inc.1
Kymera Therapeutics, Inc.1
Matthias Griese1
NHS Greater Glasgow and Clyde1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pulmonary Eosinophilia24
Asthma17
Lung Diseases2
Anxiety Disorders1
Churg-Strauss Syndrome1
Eosinophilic Esophagitis1
Lung Diseases, Interstitial1
Mental Disorders1
Pulmonary Alveolar Proteinosis1
Pulmonary Fibrosis1

Trials

Showing 26 to 24 of 24. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.